应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ELEV Elevation Oncology, Inc.
停牌 05-13 16:55:13 EDT
0.3650
+0.0000
0.00%
最高
0.3650
最低
0.3650
成交量
0.00
今开
0.3650
昨收
0.3650
日振幅
0.00%
总市值
2,163万
流通市值
1,589万
总股本
5,925万
成交额
175.06万
换手率
0.00%
流通股本
4,353万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Elevation Oncology, Inc.盘中异动 早盘股价大跌5.83%
市场透视 · 2025-03-10
Elevation Oncology, Inc.盘中异动 早盘股价大跌5.83%
Elevation Oncology, Inc.2024财年实现净利润-44.49百万美元,同比增加2.65%
市场透视 · 2025-03-10
Elevation Oncology, Inc.2024财年实现净利润-44.49百万美元,同比增加2.65%
Elevation Oncology(ELEV.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.18美元,前值为-0.19美元,预期值为-0.23美元。
金融界 · 2025-03-07
Elevation Oncology(ELEV.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.18美元,前值为-0.19美元,预期值为-0.23美元。
Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)
财报速递 · 2025-03-07
Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)
Elevation Oncology, Inc.盘中异动 大幅拉升5.00%报0.511美元
市场透视 · 2025-03-05
Elevation Oncology, Inc.盘中异动 大幅拉升5.00%报0.511美元
Elevation Oncology, Inc.盘中异动 下午盘股价大跌5.17%报0.497美元
市场透视 · 2025-03-04
Elevation Oncology, Inc.盘中异动 下午盘股价大跌5.17%报0.497美元
Elevation Oncology, Inc.盘中异动 急速下跌5.07%报0.522美元
市场透视 · 2025-02-28
Elevation Oncology, Inc.盘中异动 急速下跌5.07%报0.522美元
Elevation Oncology, Inc.盘中异动 早盘快速上涨5.38%报0.565美元
市场透视 · 2025-02-26
Elevation Oncology, Inc.盘中异动 早盘快速上涨5.38%报0.565美元
Elevation Oncology, Inc.盘中异动 早盘急速下跌5.02%报0.560美元
市场透视 · 2025-02-25
Elevation Oncology, Inc.盘中异动 早盘急速下跌5.02%报0.560美元
Elevation Oncology, Inc.盘中异动 大幅下跌5.43%报0.615美元
市场透视 · 2025-02-22
Elevation Oncology, Inc.盘中异动 大幅下跌5.43%报0.615美元
Elevation Oncology, Inc.盘中异动 临近收盘快速下跌5.18%
市场透视 · 2025-02-20
Elevation Oncology, Inc.盘中异动 临近收盘快速下跌5.18%
Elevation Oncology, Inc.盘中异动 股价大涨5.55%
市场透视 · 2025-02-18
Elevation Oncology, Inc.盘中异动 股价大涨5.55%
Elevation Oncology, Inc.盘中异动 急速拉升5.46%
市场透视 · 2025-02-15
Elevation Oncology, Inc.盘中异动 急速拉升5.46%
Elevation Oncology, Inc.盘中异动 下午盘急速上涨5.73%报0.655美元
市场透视 · 2025-02-14
Elevation Oncology, Inc.盘中异动 下午盘急速上涨5.73%报0.655美元
Elevation Oncology, Inc.盘中异动 早盘急速下跌5.01%报0.592美元
市场透视 · 2025-02-11
Elevation Oncology, Inc.盘中异动 早盘急速下跌5.01%报0.592美元
Elevation Oncology, Inc.盘中异动 早盘大幅上涨7.76%报0.690美元
市场透视 · 2025-02-04
Elevation Oncology, Inc.盘中异动 早盘大幅上涨7.76%报0.690美元
Elevation Oncology, Inc.股价重挫12.72% 市值跌180.96万美元
市场透视 · 2025-02-03
Elevation Oncology, Inc.股价重挫12.72% 市值跌180.96万美元
Elevation Oncology, Inc.盘中异动 股价大涨5.01%报0.700美元
市场透视 · 2025-02-01
Elevation Oncology, Inc.盘中异动 股价大涨5.01%报0.700美元
Elevation Oncology, Inc.盘中异动 快速上涨5.09%
市场透视 · 2025-01-31
Elevation Oncology, Inc.盘中异动 快速上涨5.09%
Elevation Oncology, Inc.盘中异动 急速跳水5.35%
市场透视 · 2025-01-27
Elevation Oncology, Inc.盘中异动 急速跳水5.35%
加载更多
公司概况
公司名称:
Elevation Oncology, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Elevation Oncology, Inc.于2019年4月29日根据特拉华州法律注册成立。该公司是一家创新的肿瘤学公司,专注于发现和开发选择性癌症疗法,以治疗一系列实体瘤患者,这些患者的医疗需求尚未得到满足。该公司正在重新思考药物开发,寻求创新的、选择性的癌症疗法,这些疗法可以与患者独特的肿瘤特征相匹配。该公司的主要候选产品EO-3021(也称为SYSA1801或CPO102)是一种抗体药物偶联物,旨在靶向Claudin18.2,这是一种经过临床验证的分子靶点,可选择性地将细胞毒性有效载荷直接递送至表达Claudin18.2的癌细胞。
发行价格:
--
{"stockData":{"symbol":"ELEV","market":"US","secType":"STK","nameCN":"Elevation Oncology, Inc.","latestPrice":0.365,"timestamp":1753214400000,"preClose":0.365,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":43534820,"shares":59252879,"eps":-0.811777,"marketStatus":"停牌","change":0,"latestTime":"05-13 16:55:13 EDT","open":0.365,"high":0.365,"low":0.365,"amount":1750615.6832472,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.811777,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778716800000},"marketStatusCode":4,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":0.365,"volumeRatio":0},"requestUrl":"/m/hq/s/ELEV","defaultTab":"news","newsList":[{"id":"2518276444","title":"Elevation Oncology, Inc.盘中异动 早盘股价大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276444?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615836,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分,Elevation Oncology, Inc.股票出现异动,股价大幅下挫5.83%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃,换手率分别为3223.97%、699.39%、122.31%,振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、32.14%、30.70%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221037a26a3387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221037a26a3387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2518728106","title":"Elevation Oncology, Inc.2024财年实现净利润-44.49百万美元,同比增加2.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518728106?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536089,"startTime":"0","endTime":"0","summary":"3月10日,Elevation Oncology, Inc.公布财报,公告显示公司2024财年净利润为-44.49百万美元,同比增加2.65%;其中营业收入为0.00美元,每股基本收益为-0.78美元。机构评级:截至2025年3月10日,当前有6家机构对Elevation Oncology, Inc.目标价做出预测,其中目标均价为7.00美元,其中最低目标价为5.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000328a26898ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000328a26898ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517709114","title":"Elevation Oncology(ELEV.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.18美元,前值为-0.19美元,预期值为-0.23美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517709114","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517709114?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:02","pubTimestamp":1741302179,"startTime":"0","endTime":"0","summary":"Elevation Oncology(ELEV.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.18美元,前值为-0.19美元,预期值为-0.23美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070248578856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153914229","title":"Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)","url":"https://stock-news.laohu8.com/highlight/detail?id=1153914229","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153914229?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:40","pubTimestamp":1741297240,"startTime":"0","endTime":"0","summary":"Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)以上内容来自Benzinga Earnings专栏,原文如下:Elevation Oncology Q4 2024 GAAP EPS $(0.18) Beats $(0.22) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Elevation Oncology 2024年第四季度 GAAP 每股收益$(0.18) 超过预期$(0.22)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517946616","title":"Elevation Oncology, Inc.盘中异动 大幅拉升5.00%报0.511美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517946616?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:39","pubTimestamp":1741189154,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时39分,Elevation Oncology, Inc.股票出现波动,股价急速拉升5.00%。截至发稿,该股报0.511美元/股,成交量12.5556万股,换手率0.21%,振幅9.25%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为1.37%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233914abe9c666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233914abe9c666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516545946","title":"Elevation Oncology, Inc.盘中异动 下午盘股价大跌5.17%报0.497美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516545946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516545946?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:09","pubTimestamp":1741025347,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时09分,Elevation Oncology, Inc.股票出现异动,股价大幅跳水5.17%。截至发稿,该股报0.497美元/股,成交量53.0893万股,换手率0.90%,振幅9.54%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040209079637dee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040209079637dee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514330814","title":"Elevation Oncology, Inc.盘中异动 急速下跌5.07%报0.522美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330814?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:51","pubTimestamp":1740689508,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时51分,Elevation Oncology, Inc.股票出现异动,股价大幅下跌5.07%。截至发稿,该股报0.522美元/股,成交量121.62万股,换手率2.06%,振幅7.09%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280451489632f5d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280451489632f5d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856699","title":"Elevation Oncology, Inc.盘中异动 早盘快速上涨5.38%报0.565美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856699?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:37","pubTimestamp":1740580653,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时37分,Elevation Oncology, Inc.股票出现波动,股价急速拉升5.38%。截至发稿,该股报0.565美元/股,成交量9.7816万股,换手率0.17%,振幅4.57%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622373396315059&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622373396315059&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514182230","title":"Elevation Oncology, Inc.盘中异动 早盘急速下跌5.02%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514182230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514182230?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:46","pubTimestamp":1740494811,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时46分,Elevation Oncology, Inc.股票出现波动,股价快速跳水5.02%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为899.33%、663.34%、536.60%,振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.,振幅分别为100.27%、46.65%、33.50%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224651a2538ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224651a2538ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513494216","title":"Elevation Oncology, Inc.盘中异动 大幅下跌5.43%报0.615美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513494216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513494216?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:34","pubTimestamp":1740162889,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时34分,Elevation Oncology, Inc.股票出现波动,股价急速跳水5.43%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大,Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为280.17%、246.90%、136.24%,振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为76.52%、70.25%、61.26%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023449962bb195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023449962bb195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512431318","title":"Elevation Oncology, Inc.盘中异动 临近收盘快速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512431318?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:35","pubTimestamp":1739997350,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时35分,Elevation Oncology, Inc.股票出现异动,股价快速下挫5.18%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.86%。其相关个股中,Editas Medicine, Inc.、Osr Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为706.51%、257.52%、235.55%,振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 、Osr Holdings, Inc.,振幅分别为288.17%、280.70%、160.77%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220043550a24c3c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220043550a24c3c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512616551","title":"Elevation Oncology, Inc.盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512616551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512616551?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889346,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分,Elevation Oncology, Inc.股票出现波动,股价大幅拉升5.55%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为284.81%、100.70%、75.60%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Glycomimetics, Inc.,振幅分别为34.04%、22.30%、18.69%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822354796279811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822354796279811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511194690","title":"Elevation Oncology, Inc.盘中异动 急速拉升5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511194690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511194690?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:01","pubTimestamp":1739552475,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时01分,Elevation Oncology, Inc.股票出现波动,股价大幅拉升5.46%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。其相关个股中,Moleculin Biotech, Inc.、Allogene Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2834.39%、742.58%、572.17%,振幅较大的相关个股有Moleculin Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为71.65%、70.63%、66.45%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021501011696233dc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021501011696233dc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511575995","title":"Elevation Oncology, Inc.盘中异动 下午盘急速上涨5.73%报0.655美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511575995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511575995?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:21","pubTimestamp":1739470910,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时21分,Elevation Oncology, Inc.股票出现异动,股价快速上涨5.73%。截至发稿,该股报0.655美元/股,成交量89.0346万股,换手率1.51%,振幅3.97%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214022150a244d96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214022150a244d96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510808693","title":"Elevation Oncology, Inc.盘中异动 早盘急速下跌5.01%报0.592美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510808693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510808693?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:42","pubTimestamp":1739284922,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时42分,Elevation Oncology, Inc.股票出现异动,股价大幅跳水5.01%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体跌幅为1.34%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2276.24%、597.13%、236.25%,振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.,振幅分别为33.04%、31.80%、31.17%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224203a241fd6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224203a241fd6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508463768","title":"Elevation Oncology, Inc.盘中异动 早盘大幅上涨7.76%报0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508463768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508463768?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:24","pubTimestamp":1738682696,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时24分,Elevation Oncology, Inc.股票出现异动,股价大幅拉升7.76%。截至发稿,该股报0.690美元/股,成交量13.6445万股,换手率0.23%,振幅4.23%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.88%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204232456a2393368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204232456a2393368&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508728141","title":"Elevation Oncology, Inc.股价重挫12.72% 市值跌180.96万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508728141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508728141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593121,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分,Elevation Oncology, Inc.股票出现波动,股价大幅跳水12.72%。截至发稿,该股报0.605美元/股,成交量14.5441万股,换手率0.25%,振幅0.16%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032232019616fb63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032232019616fb63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508993316","title":"Elevation Oncology, Inc.盘中异动 股价大涨5.01%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508993316?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:27","pubTimestamp":1738344451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时27分,Elevation Oncology, Inc.股票出现波动,股价快速上涨5.01%。截至发稿,该股报0.700美元/股,成交量62.0151万股,换手率1.05%,振幅4.79%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为1.73%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020101273296150072&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020101273296150072&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ELEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507673583","title":"Elevation Oncology, Inc.盘中异动 快速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507673583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507673583?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:28","pubTimestamp":1738254494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时28分,Elevation Oncology, Inc.股票出现异动,股价大幅上涨5.09%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃,换手率分别为1643.06%、234.26%、212.46%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ,振幅分别为65.98%、61.86%、56.41%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131002815abbd6169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131002815abbd6169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506306220","title":"Elevation Oncology, Inc.盘中异动 急速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506306220?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:36","pubTimestamp":1737988572,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时36分,Elevation Oncology, Inc.股票出现异动,股价急速下挫5.35%。Elevation Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大,Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃,换手率分别为737.03%、47.30%、41.57%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为65.16%、53.75%、34.60%。Elevation Oncology, Inc.公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272236129874b025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272236129874b025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELEV","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.elevationoncology.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.013},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.0668},{"period":"6month","weight":0.0984},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Elevation Oncology, Inc.于2019年4月29日根据特拉华州法律注册成立。该公司是一家创新的肿瘤学公司,专注于发现和开发选择性癌症疗法,以治疗一系列实体瘤患者,这些患者的医疗需求尚未得到满足。该公司正在重新思考药物开发,寻求创新的、选择性的癌症疗法,这些疗法可以与患者独特的肿瘤特征相匹配。该公司的主要候选产品EO-3021(也称为SYSA1801或CPO102)是一种抗体药物偶联物,旨在靶向Claudin18.2,这是一种经过临床验证的分子靶点,可选择性地将细胞毒性有效载荷直接递送至表达Claudin18.2的癌细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":1.046898},{"month":2,"riseRate":0.5,"avgChangeRate":0.054514},{"month":3,"riseRate":0.5,"avgChangeRate":0.031686},{"month":4,"riseRate":0.75,"avgChangeRate":0.182167},{"month":5,"riseRate":0.5,"avgChangeRate":0.070175},{"month":6,"riseRate":0.25,"avgChangeRate":-0.28136},{"month":7,"riseRate":0,"avgChangeRate":-0.14758},{"month":8,"riseRate":0.25,"avgChangeRate":-0.181997},{"month":9,"riseRate":0,"avgChangeRate":-0.178306},{"month":10,"riseRate":0.25,"avgChangeRate":-0.075221},{"month":11,"riseRate":0.5,"avgChangeRate":-0.038591},{"month":12,"riseRate":0.5,"avgChangeRate":-0.034245}],"exchange":"NASDAQ","name":"Elevation Oncology, Inc.","nameEN":"Elevation Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Elevation Oncology, Inc.(ELEV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Elevation Oncology, Inc.(ELEV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Elevation Oncology, Inc.,ELEV,Elevation Oncology, Inc.股票,Elevation Oncology, Inc.股票老虎,Elevation Oncology, Inc.股票老虎国际,Elevation Oncology, Inc.行情,Elevation Oncology, Inc.股票行情,Elevation Oncology, Inc.股价,Elevation Oncology, Inc.股市,Elevation Oncology, Inc.股票价格,Elevation Oncology, Inc.股票交易,Elevation Oncology, Inc.股票购买,Elevation Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Elevation Oncology, Inc.(ELEV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Elevation Oncology, Inc.(ELEV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}